20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
On June 13, 2019, The University of Southern California’s (USC’s) $215 million settlement to resol...
Read More >
The Chicago City Council just approved what is likely the most expansive predictive scheduling law i...
Read More >
With the coronavirus sweeping through major manufacturing hubs in China, the government has mandated...
Read More >
This week, Congress wrapped a bow on 2019 with some significant legislative accomplishments. For exa...
Read More >
The California Legislature has enacted strict requirements regulating the content that appears on em...
Read More >
Seyfarth Synopsis: On February 10, 2020, Judge Chutkan granted the Office of Management and Budget’...
Read More >